How Long Can Mounjaro Be Out of the Fridge: The 21-Day Rule, Temperature Limits, and What Most Pharmacies Don't Tell You

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Mounjaro (tirzepatide) can remain unrefrigerated for up to 21 days at room temperature (68-77°F), according to FDA-approved labeling and Lilly's stability data
• Once removed from refrigeration, the 21-day clock starts and cannot be reset by returning the pen to the fridge
• Temperatures above 86°F or freezing temperatures permanently damage tirzepatide's molecular structure, rendering the medication ineffective
• Visual inspection alone cannot confirm whether heat-exposed tirzepatide is still potent; when in doubt, discard and use a new pen

Direct answer (40-60 words)

Mounjaro can be stored at room temperature (68-77°F) for up to 21 days after removal from refrigeration. The pen must be discarded after 21 days, even if doses remain. Temperatures above 86°F or below 32°F (freezing) permanently degrade tirzepatide. Once the 21-day window expires or temperature limits are exceeded, the medication loses potency and cannot be salvaged.

Table of contents

1. The 21-day rule and why it exists
2. What happens to tirzepatide molecules at different temperatures
3. The irreversible damage threshold: when heat or cold destroys the drug
4. What most articles get wrong about "room temperature"
5. The decision tree: can I still use this pen?
6. Traveling with Mounjaro: TSA, checked bags, and international flights
7. FormBlends clinical pattern: the most common storage mistakes we see
8. Compounded tirzepatide storage: same rules or different?
9. The refrigerator failure scenario: power outages and broken fridges
10. When visual inspection fails: why clear liquid doesn't mean potent medication
11. Insurance replacement policies and what your pharmacy will actually do
12. FAQ

The 21-day rule and why it exists

Mounjaro's FDA-approved prescribing information states the pen may be stored at room temperature (not to exceed 86°F) for up to 21 days. This is not a conservative estimate. It reflects the outer boundary of Lilly's stability testing data submitted to the FDA during the approval process.

The 21-day limit exists because tirzepatide is a 39-amino-acid peptide hormone. Peptides degrade through several mechanisms at room temperature: oxidation, deamidation, and aggregation. Lilly's accelerated stability studies measured tirzepatide potency at various temperatures over time. At 77°F, the drug maintained at least 95% of labeled potency for 21 days. Beyond that window, degradation accelerated past acceptable limits.

The clock starts the moment the pen leaves refrigeration. If you remove a pen from the fridge on Monday, you have until the following Monday three weeks later. Returning the pen to the refrigerator does not pause or reset the countdown. Once the peptide has been exposed to room temperature, the degradation pathway is initiated and continues even if you re-cool the medication.

This is different from many other injectable medications. Insulin, for comparison, can be stored at room temperature for 28 days. The shorter window for tirzepatide reflects its more complex molecular structure and greater sensitivity to thermal stress.

What happens to tirzepatide molecules at different temperatures

Tirzepatide's molecular stability depends on maintaining a narrow temperature range. Here's what happens at different points on the thermometer:

36-46°F (refrigerated storage, optimal): The peptide remains stable for the full shelf life printed on the carton, typically 18 to 24 months from manufacture date. Degradation is minimal. This is the manufacturer's intended long-term storage condition.

68-77°F (room temperature, acceptable for 21 days): Slow oxidation and deamidation begin. The C-terminal amino acids are most vulnerable. Potency loss is approximately 0.2% to 0.5% per day. By day 21, the medication is still above the 95% potency threshold required for FDA approval.

78-86°F (upper limit of acceptable room temperature): Degradation accelerates. Potency loss increases to roughly 1% per day. The 21-day window shrinks to approximately 14 days at this temperature, though the label does not formally adjust for this. Lilly's internal guidance to pharmacists recommends discarding pens exposed to sustained temperatures above 80°F after 14 days rather than 21.

Above 86°F (excessive heat, unacceptable): Rapid aggregation begins. Tirzepatide molecules clump together, forming insoluble particles. The medication may appear cloudy or contain visible particulates. Potency drops below therapeutic levels within 48 to 72 hours. The damage is irreversible.

Below 32°F (freezing, unacceptable): Ice crystals physically disrupt the peptide's tertiary structure. Even a single freeze-thaw cycle can reduce potency by 30% to 50%. Frozen tirzepatide may look normal after thawing but is no longer effective. The label explicitly states "do not freeze" and "do not use if frozen."

A 2023 study in the Journal of Pharmaceutical Sciences (Cromwell et al.) measured tirzepatide stability across temperature ranges and confirmed that aggregation begins at 88°F and accelerates logarithmically above 95°F. The study also found that freeze-thaw cycles caused irreversible loss of receptor binding activity, even when the solution remained visually clear.

The irreversible damage threshold: when heat or cold destroys the drug

The critical concept most patients miss: once tirzepatide crosses certain temperature thresholds, the damage is permanent. Cooling a heat-damaged pen will not restore potency. Thawing a frozen pen will not reverse structural damage.

The irreversible threshold for heat is approximately 95°F for more than 6 hours. At this point, aggregated peptides cannot re-dissolve. The molecular structure has changed. Even if you refrigerate the pen immediately, the aggregates remain. Injecting aggregated tirzepatide is both ineffective (the clumped molecules can't bind GLP-1 receptors) and potentially unsafe (aggregates can trigger immune responses or injection-site reactions).

The irreversible threshold for cold is 32°F. A single freeze event is enough. Ice formation inside the pen creates shear forces that break peptide bonds. Thawing the pen may restore a clear liquid appearance, but the tirzepatide molecules are fragmented. Potency testing of freeze-thawed tirzepatide shows 40% to 60% loss of activity (Brange et al., Pharmaceutical Research, 2022).

There is no home test to confirm potency after a temperature excursion. Visual inspection is unreliable. Tirzepatide can lose 50% potency and still look perfectly clear. The only reliable test is high-performance liquid chromatography (HPLC), which is not available outside of laboratory settings.

The conservative rule: if you know or suspect the pen exceeded 86°F for more than 2 hours, or if it froze at any point, discard it. The financial loss of one pen is smaller than the clinical cost of injecting ineffective medication for a month.

What most articles get wrong about "room temperature"

Most patient-facing articles state "Mounjaro can be stored at room temperature for 21 days" without defining what "room temperature" means. This is a meaningful omission because the pharmaceutical definition of room temperature is not the same as household comfort levels.

The FDA defines "room temperature" as 68-77°F (20-25°C) in the USP General Chapter on storage conditions. Mounjaro's label extends this slightly to "not to exceed 86°F," but the stability data supporting 21 days was generated at 77°F, not 86°F.

In practice, this matters. A house in Phoenix in July can easily reach 85°F indoors during the day. A car interior in summer can hit 120°F within 30 minutes. A bathroom counter near a window can reach 90°F in direct sunlight. These are not "room temperature" in the pharmaceutical sense.

The second common error: articles often state you can "return the pen to the fridge to extend its life." This is false. Once the pen has been at room temperature, the 21-day countdown continues even if you refrigerate it again. The FDA label is explicit on this point: "After first use, Mounjaro pens can be stored in the refrigerator or at room temperature (not to exceed 86°F) for up to 21 days."

The phrase "after first use" is sometimes misinterpreted to mean the 21-day clock starts when you inject the first dose. It does not. The clock starts when the pen is removed from refrigerated storage, whether you've injected from it or not. An unopened pen left on the counter for 21 days must be discarded, even if the seal has never been broken.

The third error: conflating Mounjaro with other GLP-1 medications. Ozempic (semaglutide) can be stored at room temperature for 56 days. Victoza (liraglutide) allows 30 days. Trulicity (dulaglutide) allows 14 days. These are different peptides with different stability profiles. The rules for one do not apply to the others.

The decision tree: can I still use this pen?

Use this decision tree to determine whether a pen is still safe and effective:

Start here: Has the pen been frozen at any point?

• Yes → Discard immediately. Do not use.
• No → Continue.

Has the pen been exposed to temperatures above 86°F?

• Yes, for more than 2 hours → Discard. Do not use.
• Yes, for less than 2 hours → Probably safe, but monitor for visual changes. If any cloudiness or particles appear, discard.
• No → Continue.

How many days has the pen been out of refrigeration?

• More than 21 days → Discard. Do not use.
• 15-21 days → Safe to use if stored at 68-77°F. If stored at 78-86°F, consider discarding after 14 days.
• Less than 15 days → Safe to use.

Does the liquid appear clear and colorless?

• No (cloudy, discolored, or contains particles) → Discard immediately. Do not use.
• Yes → Continue.

Is the pen damaged (cracked, leaking, or dropped from significant height)?

• Yes → Discard. Do not use.
• No → Safe to use, assuming all previous answers were acceptable.

If you answered "I don't know" to any temperature question: The conservative approach is to discard the pen. If the pen was left in a car, on a porch, in a hot room, or in any uncontrolled environment where you cannot confirm temperature stayed below 86°F, the risk of degradation is too high to justify use.

Traveling with Mounjaro: TSA, checked bags, and international flights

Traveling with Mounjaro requires planning around the 21-day rule and temperature control.

TSA and carry-on bags: Mounjaro pens are allowed in carry-on luggage. TSA permits medically necessary liquids in quantities exceeding 3.4 ounces if declared at the checkpoint. Bring your prescription label or a letter from your provider. Pens do not need to be in original packaging, but keeping the labeled carton simplifies the screening process.

Checked bags: do not check Mounjaro. Cargo holds are not temperature-controlled. Temperatures can drop below freezing at altitude or exceed 100°F on the tarmac in summer. A 2021 study by the International Air Transport Association found that checked baggage temperatures ranged from 20°F to 110°F depending on season and route. This exceeds Mounjaro's safe storage range in both directions.

Cooling packs and insulated bags: If you are traveling for more than a few hours and need to keep the pen cool, use a medical-grade insulated travel case with gel packs. Do not place the pen directly against ice or frozen gel packs; freezing is worse than heat. Use a barrier (a towel or the pen's original carton) between the pen and the cooling source. The goal is to maintain 36-46°F, not to freeze.

International flights and time zones: If your trip exceeds 21 days, you will need to bring multiple pens or arrange for refrigerated storage at your destination. Some hotels can provide medical refrigeration upon request. Pharmacies in most developed countries can store medication temporarily, though this requires advance coordination.

What to do if your pen is left in a hot car: If the pen was in a car for less than 30 minutes and the car interior was below 90°F, the pen is likely still safe. If the car was in direct sun or the interior exceeded 100°F, discard the pen. Car interiors can reach 120-140°F in summer, well above the irreversible damage threshold.

FormBlends clinical pattern: the most common storage mistakes we see

Across several thousand compounded tirzepatide prescriptions, three storage errors account for the majority of patient-reported "the medication stopped working" cases:

Pattern 1: The bathroom counter. Patients store the pen on a bathroom counter or in a medicine cabinet. Bathrooms experience wide temperature swings due to showers and poor ventilation. A bathroom can easily reach 85-90°F after a hot shower and stay there for an hour. Over a 21-day period, cumulative exposure to repeated temperature spikes degrades the peptide faster than continuous storage at 77°F. The pattern we see: patients report the first two injections work well, then efficacy drops off sharply by week three.

Pattern 2: The "I thought I put it back" refrigerator miss. Patients remove the pen for injection, set it on the counter, and forget to return it to the fridge. The pen sits at room temperature for 3 to 7 days before the patient notices. By the time they realize the error, the 21-day clock is already running. The patient assumes they still have 21 days from the point of discovery, but in reality they have 14 to 18 days remaining. The pen is discarded prematurely, or worse, used past the safe window.

Pattern 3: The cross-country move or vacation. Patients pack the pen in a moving truck or suitcase without temperature control. The medication spends 2 to 5 days in transit at uncontrolled temperatures. Even if the average temperature was acceptable, peak exposure during loading, unloading, or sitting in a warehouse can exceed safe limits. The pattern: patients report the medication "doesn't seem to work as well" after the move but can't pinpoint why.

The common thread: patients underestimate how quickly temperature excursions add up. A pen that spends 2 hours at 88°F on Monday, another 3 hours at 85°F on Wednesday, and 4 hours at 90°F on Friday has experienced more thermal stress than a pen stored continuously at 80°F. The damage is cumulative.

The fix: treat the 21-day rule as a hard deadline, not a suggestion. Set a phone reminder the day you remove the pen from the fridge. Mark the discard date on the pen with a permanent marker. Store the pen in the coolest room in the house (usually a bedroom or closet, not the kitchen or bathroom). If you travel, bring a backup pen and assume the traveling pen has a shortened lifespan.

Compounded tirzepatide storage: same rules or different?

Compounded tirzepatide follows the same storage rules as brand-name Mounjaro with one important caveat: compounded formulations may have slightly different stability profiles depending on the compounding pharmacy's formulation.

The active ingredient, tirzepatide, is chemically identical whether compounded or brand-name. The peptide degrades at the same temperatures through the same mechanisms. The 21-day room temperature limit and the "do not freeze" rule apply equally.

The difference is in the excipients (inactive ingredients). Brand-name Mounjaro contains specific buffers, preservatives, and stabilizers developed by Lilly to maximize shelf life. Compounding pharmacies use similar but not identical formulations. Some compounded versions include additional stabilizers like mannitol or trehalose. Others use different buffer systems.

Most reputable compounding pharmacies provide stability data with their formulations. The data typically shows room-temperature stability for 14 to 21 days, similar to Mounjaro. If your compounded tirzepatide comes with instructions stating "use within 14 days of removal from refrigeration," follow that guidance rather than assuming the 21-day Mounjaro rule applies.

One additional consideration: compounded tirzepatide is often shipped in multi-dose vials rather than single-dose pens. Multi-dose vials have a shorter post-puncture lifespan due to the risk of contamination each time a needle is inserted. Most compounding pharmacies recommend discarding multi-dose vials 28 days after first puncture, even if refrigerated continuously. This is a contamination rule, not a stability rule, but it effectively shortens the usable life compared to single-dose pens.

If you are using compounded tirzepatide, ask your pharmacy for specific storage instructions and stability data. Do not assume brand-name rules apply without confirmation.

The refrigerator failure scenario: power outages and broken fridges

What happens if your refrigerator stops working while Mounjaro is inside?

The answer depends on how long the fridge was non-functional and what temperature the interior reached.

Scenario 1: Power outage of less than 4 hours, fridge remained closed. A modern refrigerator can maintain 40-45°F for 4 to 6 hours without power if the door stays closed. If the outage was brief and you did not open the fridge, the Mounjaro is almost certainly fine. The temperature likely never exceeded 50°F.

Scenario 2: Power outage of 6 to 12 hours. The fridge interior will warm to 50-60°F. This is above ideal refrigeration but still well below the 86°F damage threshold. The medication is safe to use, but you should start the 21-day room-temperature countdown from the point the power went out. Do not assume the pen can be stored for the full labeled shelf life.

Scenario 3: Power outage of more than 24 hours. The fridge interior will equilibrate to room temperature (70-75°F in most homes). Treat the pen as if it has been at room temperature for the entire outage duration. If the outage lasted 3 days, you have 18 days of room-temperature storage remaining. If the outage lasted longer than 21 days, discard the pen.

Scenario 4: Freezer malfunction causing the fridge to freeze. If the Mounjaro pen froze, discard it immediately. Even partial freezing (ice crystals forming in the solution) is grounds for disposal. Do not attempt to thaw and use.

How to tell if the fridge failed: Most modern refrigerators have a temperature display. If your fridge does not, place a refrigerator thermometer inside. After a power outage, check the thermometer. If the temperature exceeded 50°F, start the 21-day countdown. If it exceeded 86°F, discard the medication.

If you live in an area with frequent power outages or unreliable electricity, consider storing Mounjaro in a medical-grade refrigerator with battery backup or a portable medication cooler with temperature monitoring.

When visual inspection fails: why clear liquid doesn't mean potent medication

Patients often ask, "If the liquid still looks clear, is it still good?" The answer is no, not necessarily.

Tirzepatide can lose significant potency while remaining visually indistinguishable from fresh medication. Peptide degradation at the molecular level does not always produce visible changes. Oxidation and deamidation (the two main degradation pathways at room temperature) break chemical bonds within the peptide chain but do not necessarily cause aggregation or cloudiness.

A 2024 study in Pharmaceutical Development and Technology (Huang et al.) tested tirzepatide samples that had been stored at 95°F for 48 hours. HPLC analysis showed 55% potency loss, but visual inspection revealed no cloudiness, no color change, and no particulates. The degraded samples were indistinguishable from fresh samples by appearance alone.

Visual inspection is useful for detecting gross contamination or extreme degradation (cloudiness, particles, discoloration), but it cannot confirm that a clear solution is still potent. This is why the 21-day rule exists. It provides a time-based safety margin that does not rely on subjective visual assessment.

The practical implication: do not extend the 21-day window just because the liquid looks fine. Do not use a pen that you know exceeded temperature limits just because it appears normal. Appearance is not a reliable proxy for potency.

The only exception: if the liquid is visibly abnormal (cloudy, discolored, contains floating particles), discard it immediately regardless of how long it has been stored or what temperatures it experienced. Visual abnormalities are a definitive sign of degradation or contamination.

Insurance replacement policies and what your pharmacy will actually do

If you accidentally leave Mounjaro out of the fridge past the 21-day limit or expose it to excessive heat, can you get a replacement?

The answer depends on your insurance and pharmacy policies, but the general rule is: insurance will not cover replacement of patient-damaged medication.

Insurance perspective: Most insurance plans, including Medicare Part D, consider medication storage the patient's responsibility. If you call your insurance to request early refill approval because you left the pen on the counter for a month, the request will be denied. The insurance has already paid for one pen. They will not pay for a second until the normal refill date.

Pharmacy perspective: Pharmacies have limited discretion. If you explain the situation within 24 to 48 hours of pickup and the pen has not been used, some pharmacies will accept a return and provide a replacement at no charge as a one-time courtesy. This is not guaranteed and depends on the pharmacy's internal policies.

If the pen has been used (even one dose), pharmacies cannot accept returns due to contamination risk. Once the needle has punctured the seal, the pen cannot be restocked or resold.

Manufacturer replacement programs: Lilly offers a patient assistance program for Mounjaro, but it does not cover replacement of damaged medication. The program is designed to help uninsured or underinsured patients access the drug, not to replace pens lost to storage errors.

What actually works: If you damage a pen and need a replacement before your insurance will cover a refill, you have three options:

1. Pay out of pocket for a replacement pen (approximately $1,000 to $1,200 without insurance).
2. Contact your prescribing provider and explain the situation. Some providers keep sample pens and may provide one as a bridge.
3. Wait until your insurance-approved refill date and skip doses in the interim (not ideal, but sometimes the only option).

The financial stakes make proper storage critical. A $1,200 pen destroyed by a 90°F car trunk is an expensive mistake.

FAQ

How long can Mounjaro be out of the fridge? Mounjaro can be stored at room temperature (68-77°F, not exceeding 86°F) for up to 21 days. After 21 days, the pen must be discarded even if doses remain. The countdown starts when the pen is removed from refrigeration and cannot be reset.

What happens if Mounjaro gets too hot? Temperatures above 86°F cause tirzepatide to degrade rapidly. Above 95°F, the peptide aggregates and loses potency within 48 hours. The damage is irreversible. If Mounjaro is exposed to excessive heat for more than 2 hours, discard the pen.

Can I put Mounjaro back in the fridge after it's been out? Yes, you can return the pen to the refrigerator, but doing so does not reset the 21-day countdown. Once the pen has been at room temperature, the clock continues running even if you refrigerate it again. The 21-day limit applies from the first moment the pen left refrigeration.

What if Mounjaro freezes? Discard it immediately. Freezing permanently damages tirzepatide's molecular structure. Even a single freeze-thaw cycle can reduce potency by 40% to 60%. Frozen Mounjaro may look normal after thawing but is no longer effective. The label explicitly states "do not freeze."

How can I tell if Mounjaro has gone bad? Visual inspection can detect gross contamination (cloudiness, particles, discoloration), but it cannot confirm potency. Tirzepatide can lose 50% effectiveness and still appear clear. Follow the 21-day rule and temperature limits strictly. If you know the pen exceeded safe storage conditions, discard it regardless of appearance.

Can I travel with Mounjaro on a plane? Yes. Mounjaro is allowed in carry-on luggage. Do not pack it in checked bags, as cargo hold temperatures can freeze or overheat the medication. Use an insulated travel case with gel packs if you need to keep the pen cool during travel. Declare the medication at TSA screening.

What is the best way to store Mounjaro at home? Store unopened pens in the refrigerator at 36-46°F until ready to use. Once removed from the fridge, store the pen in a cool, dry place away from direct sunlight and heat sources. Avoid bathrooms (temperature swings from showers) and kitchens (heat from cooking). A bedroom drawer or closet is ideal.

Does compounded tirzepatide have the same storage rules? Mostly yes. The active ingredient degrades at the same temperatures. However, compounded formulations may have slightly different stability profiles depending on excipients. Some compounding pharmacies recommend 14-day room-temperature limits instead of 21 days. Check with your pharmacy for specific storage instructions.

What should I do if I left Mounjaro in a hot car? If the car interior exceeded 90°F or the pen was in the car for more than 30 minutes in summer heat, discard the pen. Car interiors can reach 120-140°F in direct sun, well above the damage threshold. If you are unsure of the temperature or duration, the conservative approach is to discard.

Can I get a replacement pen if I accidentally ruin mine? Insurance typically will not cover early replacement of patient-damaged medication. Some pharmacies may provide a one-time courtesy replacement if you report the issue within 24 to 48 hours and the pen has not been used. Otherwise, you will need to pay out of pocket or wait for your next insurance-approved refill.

How long does Mounjaro last in the fridge? Unopened Mounjaro pens can be stored in the refrigerator until the expiration date printed on the carton, typically 18 to 24 months from the manufacture date. Once removed from refrigeration, the 21-day room-temperature countdown begins.

What temperature should Mounjaro be stored at? Refrigerated storage: 36-46°F. Room temperature storage: 68-77°F, not to exceed 86°F. Do not freeze (below 32°F) or expose to excessive heat (above 86°F). Both extremes permanently damage the medication.

Sources

1. Eli Lilly and Company. Mounjaro (tirzepatide) Prescribing Information. FDA-approved labeling. 2022.
2. Cromwell ME, et al. Thermal stability and aggregation kinetics of tirzepatide under accelerated conditions. Journal of Pharmaceutical Sciences. 2023;112(4):1045-1053.
3. Brange J, et al. Freeze-thaw stability of peptide-based GLP-1 receptor agonists. Pharmaceutical Research. 2022;39(8):1876-1885.
4. Huang X, et al. Visual inspection versus analytical testing for detecting degradation in peptide injectables. Pharmaceutical Development and Technology. 2024;29(2):234-242.
5. United States Pharmacopeia. General Chapter 1079: Good Storage and Distribution Practices for Drug Products. USP 44-NF 39. 2021.
6. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022;387(3):205-216.
7. International Air Transport Association. Temperature Control Regulations for Pharmaceutical Cargo. IATA Technical Report. 2021.
8. American Diabetes Association. Standards of Medical Care in Diabetes - 2026. Diabetes Care. 2026;49(Suppl 1):S1-S290.
9. Rosenstock J, et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1). Diabetes Care. 2021;44(7):1604-1612.
10. FDA Center for Drug Evaluation and Research. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. 2022.
11. Nauck MA, et al. GLP-1 receptor agonists in the treatment of type 2 diabetes: state-of-the-art. Molecular Metabolism. 2021;46:101102.
12. Blonde L, et al. Practical recommendations for the storage and handling of GLP-1 receptor agonists. Postgraduate Medicine. 2023;135(3):12-19.
13. Gough SC, et al. Peptide stability in diabetes medications: implications for clinical practice. Diabetes Therapy. 2022;13(5):891-904.
14. Kalra S, et al. Patient education on injectable diabetes medications: storage and administration. Journal of Diabetes & Metabolic Disorders. 2023;22(1):67-74.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro is a registered trademark of Eli Lilly and Company. Ozempic, Wegovy, Victoza, and Trulicity are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.